Citation Impact
Citing Papers
Doxycycline for osteoarthritis of the knee or hip
2012
Single dose oral analgesics for acute postoperative pain in adults
2011
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
2016
Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis
2010
Re-establishing immunological self-tolerance in autoimmune disease
2012 StandoutNobel
Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease
2020
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
2012 Standout
The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis
2010
New pharmacologic approaches in the management of osteoarthritis
2010
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
2008 Standout
Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies
2014 Standout
Data Extraction Errors in Meta-analyses That Use Standardized Mean Differences
2007
Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study
2010
Rheumatoid arthritis
2016 Standout
Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach
2018 Standout
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
The effects of oral glucosamine on joint health: is a change in research approach needed?
2009
Structural and Symptomatic Efficacy of Glucosamine and Chondroitin in Knee Osteoarthritis
2003
OARSI guidelines for the non-surgical management of knee osteoarthritis
2014 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement
2012 Standout
Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales
2013
Non-specific low back pain
2016 Standout
Patient-Driven Outcomes in Rheumatoid Arthritis
2009
Non‐Steroidal Anti‐Inflammatory Drugs, Cyclooxygenase‐2 and the Bone Healing Process
2007
Glucosamine Sulfate Use and Delay of Progression of Knee Osteoarthritis
2002
Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis – meta-analysis
2011
Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation
2011 StandoutNobel
A systematic review of the global prevalence of low back pain
2012 Standout
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
2017 Standout
Assessing equity in systematic reviews: realising the recommendations of the Commission on Social Determinants of Health
2010
What a difference a year makes: Reflections on the ACR recommendations for the medical management of osteoarthritis
2001
Osteoarthritis
2015 Standout
Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors
2009
Damned if you do, damned if you don't: subgroup analysis and equity
2011
Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: A randomized, double‐blind, placebo‐controlled study using acetaminophen as a side comparator
2007
Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials
2015
Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis
2007
Chondroitin and Glucosamine in the Management of Osteoarthritis: An Update
2013
Graphical Tools for Network Meta-Analysis in STATA
2013 Standout
Evidence summaries: the evolution of a rapid review approach
2012
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Systemic Lupus Erythematosus
2011 Standout
The efficacy and safety of abatacept in patients with non–life‐threatening manifestations of systemic lupus erythematosus: Results of a twelve‐month, multicenter, exploratory, phase IIb, randomized, double‐blind, placebo‐controlled trial
2010
Regulatory T Cells Control Antigen-Specific Expansion of Tfh Cell Number and Humoral Immune Responses via the Coreceptor CTLA-4
2014 StandoutNobel
Medical literature, vena cava filters and evidence of efficacy
2013
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Results of a two‐year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate
2008
Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials
2007
Glucosamine for pain in osteoarthritis: Why do trial results differ?
2007
Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy
2007
Multiple treg suppressive modules and their adaptability
2012 StandoutNobel
Rheumatoid arthritis
2010 Standout
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
2017 Standout
OARSI recommendations for the management of hip and knee osteoarthritis
2010
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview
2009
Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials
2009
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
2016 StandoutNobel
Systematic review of non-surgical therapies for osteoarthritis of the hand: an update
2009
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
2015 Standout
Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients? – a meta-analysis of randomized controlled trials
2008
Non-specific low back pain
2011 Standout
New targets for mucosal healing and therapy in inflammatory bowel diseases
2013
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Osteoarthritis
2019 Standout
Process evaluation of complex interventions: Medical Research Council guidance
2015 Standout
Pharmacological Management of Low Back Pain
2010
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study
2009
OARSI recommendations for the management of hip and knee osteoarthritis, Part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence
2007
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Dispensable roles of Gsdmd and Ripk3 in sustaining IL-1β production and chronic inflammation in Th17-mediated autoimmune arthritis
2021 StandoutNobel
Crystalline Glucosamine Sulfate in the Treatment of Osteoarthritis: Evidence of Long-Term Cardiovascular Safety from Clinical Trials
2011
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Braces and orthoses for treating osteoarthritis of the knee
2015
Arthroscopic debridement for knee osteoarthritis
2008
Medications for Acute and Chronic Low Back Pain: A Review of the Evidence for an American Pain Society/American College of Physicians Clinical Practice Guideline
2007
A Mind-Body Program for Older Adults With Chronic Low Back Pain
2016
Ultraviolet B–Induced Maturation of CD11b-Type Langerin− Dendritic Cells Controls the Expansion of Foxp3+ Regulatory T Cells in the Skin
2017 StandoutNobel
Paracetamol versus placebo for knee and hip osteoarthritis
2019
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
Foxp3+ regulatory T cells exert asymmetric control over murine helper responses by inducing Th2 cell apoptosis
2011
Physical Therapy Treatment Effectiveness for Osteoarthritis of the Knee: A Randomized Comparison of Supervised Clinical Exercise and Manual Therapy Procedures Versus a Home Exercise Program
2005
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood
2016 StandoutNobel
Interventions for preventing obesity in children
2019 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Acupuncture for peripheral joint osteoarthritis
2010
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Animal models of autoimmune hepatitis
2010
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Choice of Comparator in Active Control Trials of New Drugs
2008
Tramadol for osteoarthritis
2006
Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans
2012 StandoutNobel
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Effect of Diacerein on Insulin Secretion and Metabolic Control in Drug-Naïve Patients With Type 2 Diabetes
2011
Industry sponsorship and research outcome
2017 Standout
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Effects of diacerein at the molecular level in the osteoarthritis disease process
2010
Works of Lara Maxwell being referenced
Method guidelines for Cochrane Musculoskeletal Group systematic reviews.
2006
Updated Method Guidelines for Cochrane Musculoskeletal Group Systematic Reviews and Metaanalyses
2013
Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis
2007
Is health equity considered in systematic reviews of the cochrane musculoskeletal group?
2008
Abatacept for Rheumatoid Arthritis: A Cochrane Systematic Review
2010
Diacerein for osteoarthritis
2014
TNF-alpha inhibitors for ankylosing spondylitis
2015
Chondroitin for osteoarthritis
2015
Rofecoxib for osteoarthritis
2005
Acetaminophen for osteoarthritis
2006
Etanercept for the treatment of rheumatoid arthritis
2013
Glucosamine therapy for treating osteoarthritis
2005
Determining the minimal clinically important differences in activity, fatigue, and sleep quality in patients with rheumatoid arthritis.
2007
Abatacept for rheumatoid arthritis
2009